Koie T, Ohyama C, Makiyama K, Shimazui T, Miyagawa T, Mizutani K, Tsuchiya T, Kato T, Nakane K. Utility of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion for Muscle-Invasive Bladder Cancer. Int J Urol. 2019;26(3):334-340.
Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C. Impact of Distance Between Donor and Recipient Hospitals on Cadaveric Kidney Transplantation Outcomes.
Clin Exp Nephrol. 2019;23(6):807-813.
Iwamoto H, Morizane S, Koie T, Shiroki R, Kawakita M, Gondo T, Matsumoto K, Habuchi T, Sunada H, Endo Y, Noma H, Takenaka A, Kanayama H
Peri-operative Efficacy and Long-Term Survival Benefit of Robotic-Assisted Radical Cystectomy in Septuagenarian Patients Compared With Younger Patients: A Nationwide Multi-Institutional Study in Japan.
Int J Clin Oncol. 2019;24(12):1588-1595.
Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Ito A, Koie T, Suda Y, Gardiner RA, Ohyama C
Clinical Significance of the LacdiNAc-glycosylated Prostate-Specific Antigen Assay for Prostate Cancer Detection. Cancer Sci. 2019;110(8):2573-2589.
Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer.
IJU Case Reports. 2019;2(4):236-239.
Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C
Sleep Disturbance Has a Higher Impact on General and Mental Quality of LifeReduction Than Nocturia: Results From the Community Health Survey in Japan. Eur Urol Focus. 2019 Nov;5(6):1120-1126
Tsuchiya T, Imanaka K, Iwaki Y, Oyama R, Hashine K, Yamaguchi A, Uemura H
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2019, 24(12):1596-1604.
Mizutani K, Horie K, Kato T, Nakane K, Kawakami K, Fujita Y, Ito M
Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy.
J Cancer Res Clin Oncol
2019;145(6):1661-1663
Mizutani K, Kawakami K, Horie K, Fujita Y, Kameyama K, Kato T, Nakane K,
Tsuchiya T, Yasuda M, Masunaga K, Kasuya Y, Masuda Y, Deguchi T, Koie T,
Ito M
Urinary exosome as a potential biomarker for urinary tract nfection.
Cell Microbiol. 2019 Jul;21(7)
Yamada Y, Ohno Y, Kato Y, Kobayashi R, Hayashi H, Miyahara S, Nakane K,
Mizutani K, Yokoi S, Fujii H, Iihara H, Ishihara T, Deguchi T, Sugiyama T, Suzuki A
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.
Cancer Chemother Pharmacol.
2019;84(5):987-992
Nakane K，Muramatsu Y，Iinuma K，Mizutani K，Makiyama K，Koie T
Utility technique of a totally intracorporeal ileal conduit afUter robot‐
assisted radical cystectomy
Int Urol 2019;26(11):1083-1084
Horie K, Tsuchiya T, Iinuma K, Maekawa Y, Nakane K, Kato T, Mizutani K, Koie T. Risk factorsand incidence of malignant neoplasms after kidney transplantation at a single institution in Japan.
Clin Exp Nephrol 2019;23(11):1323-1330.
Iinuma K, Mizutani K, Kato T, Nakane K, Tanaka H, Nakano M, Matsuo M,
Insertion During Permanent iodine-125 Implant Brachytherapy: A Case Report
Mol Clin Oncol 11(6):580-582, 2019
Kodama H, Koie T, Oikawa M, Narita T, Tanaka T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C.
Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
Int Urol Nephrol. 2020;52:671-679.
Oikawa M, Tanaka T, Narita T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Kodama H, Hashimoto Y, Koie T, Ohyama C
Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.
Pathol Oncol Res. 2020;26:2115-2121.
Tomita Y, Naito S, Sassa N, Takahashi A, Kondo T, Koie T, Obara W, Kobayashi Y, Teishima J, Takahashi M, Matsuyama H, Ueda T, Yamaguchi K, Kishida T, Shiroki R, Saika T, Shinohara N, Oya M, Kanayama HO.
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC. Clin Genitourin Cancer. 2020;18:e374-e385.
Koie T, Hashimoto Y, Imai A, Yoneyama T, Tobisawa Y, Tanaka T, Noro D,
Oikawa Suzuki T.
Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
Int Urol Nephrol. 2021;53:275-280.
IJU Case Rep. 2020;4:26-28.
Nakane K, Enomoto T, Hishida S, Tomioka M, Taniguchi T, Kato D, Takai M,
Iinuma K, Muramatsu Maekawa Y, Horie K, Mizutani K, Tsuchiya T, Yokoi S, Koie T.
The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-
Invasive Bladder Cancer at a Single Institution.
Urol Int. 2020;104:573-579.
Maekawa-Muramathu Y, Horie K, Iinuma K, Takai M, Ohzawa K, Tsuchiya T, Kato D, Taniguchi T, Ito H, Hishida S, Nakane K, Mizutani K, Koie T, Kato T
Effect of Posttransplant Diabetes Mellitus on Graft Loss After Living-Donor Kidney Transplant at a Single Institution.
Transplant Proc. 2020;52:162-168.
Iinuma K, Nakano M, Kato T, Kato D, Takai M, Maekawa Y, Nakane K, Mizutani K,
Tsuchiya T, Ishihara T, Ito M, Matsuo M, Koie T
Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With
Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy.
Urology. Aug; 142:213-220. 2020.
Takai M, Kato S, Nakano M, Fujimoto S, Iinuma K, Ishida T, Taniguchi M, Tamaki M,
Uno M, Takahashi Y, Komeda H, Koie T.
Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of
patients with castration-resistant prostate cancer: A local experience of a multicenter
retrospective study.
Asia Pac J Clin Oncol. 2021;28:1402-1411.
Kato D, Nakane K, Enomoto T, Tomioka M, Nakai C, Takai M, Iinuma K, Muramatsu
Maekawa Y, Mizutani K, Tsuchiya T, Yokoi S, Koie T.
The utility of laparoscopic partial nephrectomy with renal function preservation,
regardless of warm ischemia time, compared with laparoscopic radical nephrectomy.
Asian J Endosc Surg. 2021;14:386-393.
Horie K, Kawakami K, Fujita Y, Matsuda Y, Arai T, Suzui N, Miyazaki T, KoieT,
Mizutani K, Ito M
Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal
Cell Carcinoma with Advanced Clinicopathological Features.
Oncology. 2020;98:734-742.
Taniguchi T, Iinuma K, Kato D, Takai M, Maekawa YM, Nakane K, Mizutani K, Tsuchiya T, Nakano M, Kato T, Ito M, Kumano T, Matsuo M, Koie T
Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy.
Int J Clin Oncol. 2020;25:1711-1717
Tomioka M, Yoneyama T, Tobisawa Y, Kawase K, Nakai C, Takai M, Kato D, Iinuma K, Nakane K, Mizutani K, Hashimoto Y, Koie T.
Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer
Translational Andrology and Urology 2021 Mar;10(3):1192-1201.
Case Reports
Muramatsu-Maekawa Y, Taniguchi T, Ito H, Nakane K, Kato T, Tsuchiya T,
Miyazaki T, Koie T, Mizutani K
Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review.
J Immunother. 2020;43:134-138. Urol Case Rep. 2020;31:101145.
Takai M, Kato D, Iinuma K, Maekawa YM, Nakane K, Tsuchiya T, Yokoi S, Koie T
Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.
Koie T, Hashimoto Y, Suzuki Y, Hatayama Y, Kimura F
Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer. Case Rep
Urol. 2020;2020:5627548.
Koie T, Hagiwara N, Yamada T, Kondo H, Ito H, Tomioka M, Kawashima K, Kato D, Iinuma K, Nakane K. Usefulness of robot-assisted radical prostatectomy in a patient with oligometastatic castration-resistant prostate cancer. IJU Case Rep. 2020;4:26-28.
Tomioka K, Koie T, et al.
A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab.
Cancer Rep (Hoboken). 2021:e1356.
Tomioka M, Kawase M, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Suzui N, Miyazaki T, Koie T.
Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies
Case Reports in Urology 2021 Apr 30;2021:5543939
Koie T, Hashimoto Y, Imai A, Yoneyama T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Suzuki T. Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution. Int Urol Nephrol 2021;53:275-280.
Takai M, Kato S, Nakano M, Fujimoto S, Iinuma K, Ishida T, Taniguchi M, Tamaki M, Uno M, Takahashi Y, Komeda H, Koie T. Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study. Asia Pacif J Clin Oncol 2021;17:238-244.
Kato D, Nakane K, Enomoto T, Tomioka M, Nakai C, Takai M, Iinuma K, Muramatsu Maekawa Y, Mizutani K, Tsuchiya T, Yokoi S, Koie T. The utility of laparoscopic partial nephrectomy with renal function preservation, regardless of warm ischemia time, compared with laparoscopic radical nephrectomy. Asisn J Rndosc Surg 2021;14:386-393.
Iinuma K, Yuhara K, Kotaka H, Ozawa K, Kato D, Takai M, Nakane K, Mizutani K, Tsuchiya T, Koie T. Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy. Cancer Rep (Hoboken) 2021;4:e1321.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators (Koie T). Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. N Engl J Med 2021;384:1289-1300.
Tomioka M, Nakane K, Ozawa K, Iinuma K, Suzui N, Miyazaki T, Koie T. A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab. Cancer Rep (Hoboken) 2021;4:e1356.
Mizutani K, Ito T, Takahara K, Ando R, Ishihara T, Yasui T, Shiroki R, Miyake H, Koie T. Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab. Medicine (Baltimore) 2021;100:e25402.
Kato D, Ozawa K, Takeuchi S, Kawase M, Kawase K, Nakai C, Takai M, Iinuma K, Nakane K, Kato H, Matsuo M, Suzui N, Miyazaki T, Koie T. The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging. Curr Oncol 2021;28:1294-1301
Tomioka M, Yoneyama T, Tobisawa Y, Kawase K, Nakai C, Takai M, Kato D, Iinuma K, Nakane K, Mizutani K, Hashimoto Y, Koie T. Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer. Trans Androl Urol 2021;10:1192-1201
Muramatsu-Maekawa Y, Kawakami K, Fujita Y, Takai M, Kato D, Nakane K, Kato T, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K. Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma. Cancer Genomics Proteomics 2021;18:253-259.
Hishida S, Kawakami K, Fujita Y, Kato T, Takai M, Iinuma K, Nakane K, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K. Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel-resistant prostate cancer. Prostate 2021;81:592-602.
Iinuma K, Kameyama K, Kawada K, Fujimoto S, Takagi K, Nagai S, Ito H, Ishida T, Kawase M, Kawase K, Nakai C, Kato D, Takai M, Nakane K, Koie T. Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Curr Oncol 2021;28:1402-1411.
Iinuma K, Kawakami K, Mizutani K, Fujita Y, Yamaguchi T, Ito M, Kumano T, Matsuo M, Nakano M, Koie T, Ito M, Kato T. miRNA-93 in Serum Extracellular Vesicles Before and After Low Dose Rate Prostate Brachytherapy. Anticancer Res 2021;41:2411-2418.
Tomioka M, Kawase M, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Suzui N, Miyazaki T, Koie T. Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies. Case Rep Urol 2021;2021:5543939.
Matsuda Y, Narita S, Okubo T, Mitsuzuka K, Hatakeyama S, Koizumi A, Koie T, Kawamura S, Tochigi T, Ito A, Oyama C, Arai Y, Habuchi T. Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy. Ann Surg Oncol 2021;28:5341-5348.
Kawakami K, Fujita Y, Kato T, Horie K, Koie T, Umezawa K, Tsumoto H, Miura Y, Katagiri Y, Miyazaki T, Ohsawa I, Mizutani K, Ito M. Diagnostic potential of serum extracellular vesicles expressing prostate-specific membrane antigen in urologic malignancies. Sci Rep 2021;11:15000.
Uno H, Taniguchi T, Seike K, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Koie T. The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy. Transl Androl Urol 2021;10:2982-2989.
Takai M, Kawakami K, Fujita Y, Kato T, Kato D, Iinuma K, Koie T, Ito M, Mizutani K. Kartogenin Inhibits Prostate Cancer Cell Growth Through Smad2 Activation and Decreases Androgen Receptor Nuclear Localization. Anticancer Res 2021;41:4753-47593
Seike K, Ishida T, Taniguchi T, Fujimoto S, Kato D, Takai M, Iinuma K, Nakane K, Uno H, Tamaki M, Komeda H, Koie T. Low Body Mass Index as a Predictive Factor for Postoperative Infectious Complications after Ureterorenoscopic Lithotripsy. Medicina (Kaunas) 2021;57:1100.
Kawase M, Nakane K, Namiki S, Takeuchi Y, Ueda S, Kawase K, Nakai C, Takeuchi S, Kato D, Takai M, Iinuma K, Fuwa M, Saigo C, Miyazaki T, Morita H, Koie T. A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy. Case Rep Urol 2021;2021:8026883.
Iinuma K, Enomoto T, Kawada K, Fujimoto S, Ishida T, Takagi K, Nagai S, Ito H, Kawase M, Nakai C, Kawase K, Kato D, Takai M, Nakane K, Kameyama K, Koie T. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. J Clin Med 2021;10:5325.
Takeuchi Y, Kato D, Nakane K, Kawase K, Takai M, Iinuma K, Saigo C, Miyazaki T, Koie T. Solitary Fibrous Tumor of the Prostate: A Case Report and Literature Review. Medicina (Kaunas) 2021;57:1152.
Takeuchi S, Nakane K, Saigo C, Miyazaki T, Koie T. A Case of Muscle-Invasive Bladder Cancer With Pelvic Lymph Node Involvement Treated With Pembrolizumab and Subsequent Radical Cystectomy and Maintained No Evidence of Disease After Surgery. Cureus 2021;13:e19375.
Kato s, Takai M, Iinuma K, Fujimoto S, Nakano M, Ishida T, Uno M, Tamaki M, Taniguchi M, Komeda H, Takahashi Y, Koie T. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. The Scientific World Journal 2021;2021:8824140.
Nakane K, Enomoto T, Tomioka M, Taniguchi T, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Seike K, Hagiwara N, Uno H, Yuhara K, Koie T. Favorable surgical outcomes and perioperative complication rates after robotic radical cystectomy and intracorporeal urinary diversion at a single, low-volume center: Initial experience with 65 consecutive cases. World Journal of Clinical Surgery 2021;Issue 6:1-6.
Tatenuma T, Ebara S, Kawase M, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T, Makiyama K
Association of hospital volume with perioperative and oncological outcomes of robot
assisted laparoscopic radical prostatectomy: a retrospective multicenter cohort study.
BMC Urol. 2023;23(1):14.
Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kato D, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Inoue T
Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical
prostatectomy.
BJUI Compass. 2022;3(5):392-399.
Yamaguchi T, Sugiyama Y, Tanaka T, Kimura T, Yumura Y, Nakano M, Sugiyama T, Miura N, Goya M, Yamamoto A, Takahashi S, Miura Y, Tsuzuki T, Masumori N, Nishiyama H, Yao M, Koie T, Miyake H, Saika T, Saito S, Akimoto T, Tamada T, Ando Y, Takahashi S, Suzuki T, Hinotsu S, Kamba T
Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese
Urological Association.
Int J Urol. 2022;29)8):780-792.
Sugino Y, Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M,
Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F,
Urakami S, Inoue T
Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico
Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A
Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
Clin Genitourin Cancer. 2022;20(6):593-600.
amaguchi T, Sugiyama Y, Tanaka T, Kimura T, Yumura Y, Nakano M, Sugiyama T,
Miura N, Goya M, Yamamoto A, Takahashi S, Miura Y, Tsuzuki T, Masumori N,
Nishiyama H, Yao M, Koie T, Miyake H, Saika T, Saito S, Akimoto T, Tamada T, Ando
Y, Takahashi S, Suzuki T, Hinotsu S, Kamba T.
Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese
Urological Association. Int J Urol. 2022;29)8):780-792.
Nakane K, Yamada T, Tomioka-Inagawa R, Sugino F, Kumada N, Kawase M,
Takeuchi S, Kawase K, Kato D, Takai M, Iinuma K, Koie T
Efficacy and Safety of the "Trisection Method" Training System for Robot-Assisted
Radical Cystectomy at a Single Institution in Japan
Curr Oncol. 2022 29: 9294-304.
Nakane K, Watanabe H, Naiki T, Takahara K, Yasui T, Miyake H, Shiroki R, Koie T
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for
Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting
Biological Recurrence.
Diagnostics. 2023 13: 1661.
Iinuma K, Nakane K, Koie T
The effectiveness of off-clamp and non-renorrhaphy technique regarding postoperative
renal function in patients with partial nephrectomy
Transl Androl Urol. 2022;11(9):1222-1223.
Iinuma K, Kameyama K, Taniguchi T, Kawada K, Ishida T, Takagi K, Nagai S, Enomoto T, Tomioka M, Kawase M, Takeuchi S, Kato D, Takai M, Nakane K, Koie T
Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus
Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter,
Retrospective Cohort Study
Cancers. 2022;14)19):4579
Iinuma K, Tomioka-Inagawa R, Kameyama K, Taniguchi T, Kawada K, Ishida T, Nagai S, Enomoto T, Ueda S, Kawase M, Takeuchi S, Kawase K, Kato D, Takai M, Nakane K, Koie T
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell
Carcinoma: A Multicenter Retrospective Cohort Study.
Biomedicines. 2022;10(12):3172.
Iinuma K, Yamada T, Kameyama K, Taniguchi T, Kawada K, Ishida T, Nagai S, Enomoto T, Ueda S, Takagi K, Kawase M, Takeuchi S, Kawase K, Kato D, Takai M, Nakane K, Koie T
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor
Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter
Retrospective Real-World Cohort Study
Cancers. 2023;15(3):947.
Takai M, Kawase K, Kato D, Iinuma K, Nakane K, Koie T
Totally intracorporeal urinary diversion under robot-assisted surgery may not increase
the incidence and risk factors of surgical site infection.
Int J Urol. 2022;29(5):474-476.
Kato D, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T
Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A
retrospective multicenter cohort study in Japan (the MSUG94 group).
Asian J Endosc Surg. 2022;15(4):745-752.
Kato D, Namiki S, Ueda S, Takeuchi Y, Takeuchi S, Kawase M, Kawase K, Nakai C, Takai M, Iinuma K, Nakane K, Koie T
Validation of standardized training system for robot-assisted radical prostatectomy
comparison of perioperative and surgical outcomes between experienced surgeons and
novice surgeons at a low-volume institute in Japan.
Minim Invasive Ther Allied Technol. 2022;31(7):1103-1111.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T,
Sakaguchi K, Ishihara T, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga
F, Urakami S, Koie T
A Nomogram for Predicting Prostate Cancer with Lymph Node Involvement in Robot
Assisted Radical Prostatectomy Era: A Retrospective Multicenter Cohort Study in Japan
(The MSUG94 Group)
Diagnostics. 2022;12(10):2545.
Kawase M, Takagi K, Kawada K, Ishida T, Tomioka M, Enomoto T, Fujimoto S,
Taniguchi T, Ito H, Kameyama K, Yamada T, Kawase K, Kato D, Takai M, Iinuma K,
Nakane K, Koie T
Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients
with Penile Squamous Cell Cancer.
Curr Oncol. 2022;29(8):5466-5474.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T,
Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami
S, Koie T
The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after
Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in
Japan (The MSUG94 Group).
Medicina. 2022;58(8):990.
Takeuchi S，Iinuma K，Nakane K，Nakano M，Kawase M，Kawase K，Takai M，Kato
D，Mori T，Takano H，Kumano T，Matsuo M，Koie T
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Curr Oncol.
2023;30(3):2792-2800.
Takeuchi S, Iinuma K, Nakano M, Kawase M, Kato D, Kawase K, Takai M, Nakane K,
Ito M, Kumano T, Matsuo M, Koie T
Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center. Prostate Int. 2022;10(4):224-228.
Namiki S, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A,
Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H,
Saito K, Koga F, Urakami S, Koie T
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
Cancers2022;14(23):5803.
Yamada T, Nakane K, Enomoto T, Tomioka M, Taniguchi T, Ishida T, Ozawa K,
Takagi K, Ito H, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Yokoi S, Nakano M, Koie T
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study
Biomedicines. 2022;10(9):2243.
Tomioka-Inagawa R, Nakane K, Enomoto T, Tomioka M, Taniguchi T, Ishida T, Ozawa
K, Takagi K, Ito H, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Yokoi S, Nakano M, Koie T
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma.
Biomedicines. 2022;10(7):1609.
Sugino F, Nakane K, Kawase M, Iinuma K, Kawase K, Koie T
Endoscopic Combined Intrarenal Surgery for Renal Allograft Lithiasis using “Sheath-Connection Technique”: A Case Report.
Urol Case Rep. 2023 Jan 21;47:102331.
和文
古家琢也，中根慶太，飯沼光司，髙井 学，加藤大貴，川瀬絋太，川瀬 真，竹内慎一
ロボット支援膀胱全摘除術および尿路変向術でのトラブルシューティング Japanese Journal of Endourology and Robotics. 2022:35:249-255.
Yamaguchi T, Matsuo M, Mori T, Noda Y, Makita C, Hyodo F, Iinuma K, Nakano M, Koie T, Tanaka H
Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed.
Curr Oncol. 2023, 30, 4060-4066.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Tomioka-Inagawa R, Yamada T, Namiki S, Kumada N, Takeuchi S, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer. Life. 2023, 13, 1072.
Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Inoue T
Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group)
Jpn J Clin Oncol. 2023, 53, 443-451.
Nakane K, Watanabe H, Naiki T, Takahara K, Yasui T, Miyake H, Shiroki R, Koie T
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence
Diagnostics. 2023, 13, 1661.
Takagi K, Takahashi H, Miura T, Yamagiwa K, Kawase K, Muramatsu-Maekawa Y,
Yamaha M, Nakane K, Koie T, Minoshima K
Prognostic value of various nutritional risk markers in patients hospitalized for the treatment of genitourinary cancer: A retrospective study.
Clin Nutr ESPEN. 2023, 55, 44-50.
Ito M，Makita C，Mori T，Takano H，Kumano T，Matsuo M，Iinuma K，Kawase M， Nakane K，Nakano M，Koie T
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Curr Oncol. 2023, 30, 5680-5689.
Tsuchiya K, Kawase M, Nakane K, Nakano M, Iinuma K, Kato D, Takai M, Tobisawa Y, Mori T, Takano H, Kumano T, Matsuo M, Ito T, Koie T. Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy.
Life. 2023, 13, 1507.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T.
Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)
J Robot Surg. 2023, 17, 1609-1617.
Namiki S, Kato D, Iinuma K, Nakane K, Koie T.
Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case Report. Cureus. 2023, 15, e42954.
Tomioka M, Seike K, Uno H, Asano N, Watanabe H, Tomioka-Inagawa R, Kawase M,
Kato D, Takai M, Iinuma K, Tobisawa Y, Nakane K, Tsuchiya K, Ito T, Koie T
Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores. Diagnostics. 2023, 13, 2608.
Taniguchi T, Kawase M, Nakane K, Nakano M, Iinuma K, Kato D, Takai M,
Tobisawa Y, Mori T, Takano H, Kumano T, Matsuo M, Ito T, Koie T. Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy. Cancers. 2023, 15, 4048.
Ito H, Nakane K, Yamada T, Kobayashi K, Miyazaki T, Koie T.
Case of extragonadal germ cell tumor mimicking left adrenal tumor.
Urol Case Rep. 2023, 50, 102477.
Kawase M, Goto T, Ebara S, Tatenuma T, Sasaki T, Ishihara T, Ikehata Y, Nakayama A,
Toide M, Yoneda T, Sakaguchi K, Teishima J, Kobayashi T, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T
Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Ann Surg Oncol. 2023, 30, 6925-6933.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Yamada T, Namiki S, Kumada N, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Ito T, Koie T.
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients.
J Robot Surg. 2023, 17, 2441-2449.
Iinuma K, Nishino Y, Matsuoka K, Ihara T, Makabe S, Tanji R, Harigane Y, Ishida K, Tamaki M, Yokoi S, Hoshino H, Yuhara K, Yamada T, Kubota Y, Miwa K, Kikuchi M, Kojima Y, Mitsui T, Koie T.
The prevalence and predictive factors of nocturnal polyuria in Japanese patients with nocturia: a multicentral retrospective cohort study.
Sci Rep. 2023, 13, 18128.
Naiki T, Takahara K, Watanabe H, Nakane K, Sugiyama Y, Koie T, Shiroki R, Miyake H, Yasui T.
The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study.
Cancers. 2023, 15, 5333.
Sakaguchi K, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koie T, Koga F, Urakami S.
Early and late urinary continence outcomes after unilateral and bilateral nerve-sparing robot-assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group).
Int J Med Robot. 2023, e2593.
Kumada N, Nakane K, Yamada T, Tomioka-Inagawa R, Sugino F, Namiki S, Kawase M, Kawase K, Takeuchi S, Nakai C, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T.
Utility and safety of robot-assisted radical cystectomy in older patients with bladder cancer.
Minim Invasive Ther Allied Technol. 2023, 32, 307-313.
Murase K, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T.
The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).
J Clin Med. 2023, 12, 7732.
Morizane S, Nakane K, Tanaka T, Zennami K, Muraoka K, Ebara S, Miura N, Uemura K, Sobu R, Hoshi A, Taoka R, Sugimoto M, Noma H, Sunada H, Nishiyama H, Habuchi T, Ikeda I, Saika T, Makiyama K, Shiroki R, Masumori N, Koie T, Takenaka A.
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan.
Int J Clin Onol. 2024, 29, 64-71.
Enomoto T, Okada H, Tomita H, Iinuma K, Nakane K, Tobisawa Y, Hara A, Koie T.
Glycocalyx analysis of bladder cancer: three-dimensional images in electron microscopy and vicia villosa lectin as a marker for invasiveness in frozen sections.
Front Cell Dev Biol. 2024, 11, 1308879.
Toide M, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Sasaki T, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Inoue T, Urakami S, Koga F.
Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group).
J Robot Surg. 2024, 18, 38.
Miura T, Okuda T, Suzuki K, Okada H, Tomita H, Takada C, Mori K, Asano H, Kano S, Wakayama Y, Fukuda Y, Fukuda H, Nishio A, Kawasaki Y, Kuroda A, Suzuki K, Kamidani R, Okamoto H, Fukuta T, Kitagawa Y, Miyake T, Nakane K, Suzuki A, Yoshida T, Tetsuka N, Yoshida S, Koie T, Ogura S.
Recombinant antithrombin attenuates acute kidney injury associated with rhabdomyolysis: an in vivo animal study.
Intensive Care Med Exp. 2024, 12, 7.
Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, Nakayama A, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Inoue T, Kitamura H, Saito K, Koga F, Urakami S, Koie T.
Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group). Ann Surg Oncol. 2024, 31, 2154-2162.
Sasaki T, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Inoue T.
Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
World J Urol. 2024, 42, 152.
Nakai C, Miwa K, Yamaguchi A, Takeuchi Y, Yamaguchi M, Kitagawa Y, Koie T.
Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough-associated detrusor overactivity.
IJU Case Rep. 2024, 7, 247-249.
